232 related articles for article (PubMed ID: 18212090)
1. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables.
Sastre J; Maestro ML; Puente J; Veganzones S; Alfonso R; Rafael S; García-Saenz JA; Vidaurreta M; Martín M; Arroyo M; Sanz-Casla MT; Díaz-Rubio E
Ann Oncol; 2008 May; 19(5):935-8. PubMed ID: 18212090
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).
Bahnassy AA; Salem SE; Mohanad M; Abulezz NZ; Abdellateif MS; Hussein M; Zekri CAN; Zekri AN; Allahloubi NMA
Exp Mol Pathol; 2019 Feb; 106():90-101. PubMed ID: 30578762
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Cancer CTCs Detection Using Two FCM Protocol Approaches.
Mourtzikou A; Stamouli M; Karakitsos P; Athanasas G
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232030
[TBL] [Abstract][Full Text] [Related]
4. Determination of circulating tumor cells for prediction of recurrent colorectal cancer progression.
Kawahara H; Watanabe K; Toyama Y; Yanagisawa S; Kobayashi S; Yanaga K
Hepatogastroenterology; 2012 Oct; 59(119):2115-8. PubMed ID: 22328299
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
Abdalla TSA; Meiners J; Riethdorf S; König A; Melling N; Gorges T; Karstens KF; Izbicki JR; Pantel K; Reeh M
PLoS One; 2021; 16(6):e0252897. PubMed ID: 34111181
[TBL] [Abstract][Full Text] [Related]
7. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
[TBL] [Abstract][Full Text] [Related]
8. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
[TBL] [Abstract][Full Text] [Related]
9. EpCAM-expressing circulating tumor cells in colorectal cancer.
Nicolazzo C; Raimondi C; Francescangeli F; Ceccarelli S; Trenta P; Magri V; Marchese C; Zeuner A; Gradilone A; Gazzaniga P
Int J Biol Markers; 2017 Oct; 32(4):e415-e420. PubMed ID: 28604994
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer.
Neki K; Kawahara H; Watanabe K; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 Apr; 33(4):1769-72. PubMed ID: 23564832
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study.
Dizdar L; Fluegen G; van Dalum G; Honisch E; Neves RP; Niederacher D; Neubauer H; Fehm T; Rehders A; Krieg A; Knoefel WT; Stoecklein NH
Mol Oncol; 2019 Jul; 13(7):1548-1558. PubMed ID: 31116510
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.
Lu Y; Liang H; Yu T; Xie J; Chen S; Dong H; Sinko PJ; Lian S; Xu J; Wang J; Yu S; Shao J; Yuan B; Wang L; Jia L
Cancer; 2015 Sep; 121(17):3036-45. PubMed ID: 25945459
[TBL] [Abstract][Full Text] [Related]
14. The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer.
Divella R; Daniele A; Abbate I; Bellizzi A; Savino E; Simone G; Giannone G; Giuliani F; Fazio V; Gadaleta-Caldarola G; Gadaleta CD; Lolli I; Sabbà C; Mazzocca A
Cancer Causes Control; 2014 Nov; 25(11):1531-41. PubMed ID: 25135616
[TBL] [Abstract][Full Text] [Related]
15. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
Ilie M; Szafer-Glusman E; Hofman V; Long-Mira E; Suttmann R; Darbonne W; Butori C; Lalvée S; Fayada J; Selva E; Yu W; Marquette CH; Shames DS; Punnoose E; Hofman P
Oncotarget; 2017 Apr; 8(16):26112-26121. PubMed ID: 28212540
[TBL] [Abstract][Full Text] [Related]
16. Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®.
Gorges TM; Stein A; Quidde J; Hauch S; Röck K; Riethdorf S; Joosse SA; Pantel K
PLoS One; 2016; 11(5):e0155126. PubMed ID: 27182774
[TBL] [Abstract][Full Text] [Related]
17. Practical utility of circulating tumour cells as biomarkers in cancer chemotherapy for advanced colorectal cancer.
Otsuka K; Imai H; Soeda H; Komine K; Ishioka C; Shibata H
Anticancer Res; 2013 Feb; 33(2):625-9. PubMed ID: 23393358
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer.
Huang HB; Ge MJ
Thorac Cardiovasc Surg; 2016 Sep; 64(6):515-9. PubMed ID: 26030121
[TBL] [Abstract][Full Text] [Related]
20. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
Chen X; Wang X; He H; Liu Z; Hu JF; Li W
PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
